Reactivating PTEN in PTEN-mutated melanoma cells and PTEN-null prostate cancer cells by mRNA delivery reversed the immunosuppressive TME by promoting CD8 T-cell infiltration and lifting the expression level of proinflammatory cytokines 170. The gene discussed is PTEN; the disease is melanoma.